glp 1 drugs and rheumatoid arthritis Glucagon-like peptide its receptor agonists for the treatment of rheumatic diseases does tirzepatide help with rheumatoid
Description
Prediction of low bone mineral density in patients with inflammatory bowel diseases
Across the EVOKE and EVOKE+ trials, oral semaglutide did not slow cognitive or functional decline in 3,808 people with early Alzheimers disease, a finding that followed the Phase 3 Exenatide-PD3 trials null result in Parkinsons disease earlier that year
doi: 10.1053/j.ackd.2021.04.002
Jain AB, Kanters S, Khurana R, Kissock J, Severin N, Stafford S
Medicares search for effective obesity treatments: diets are not the answer
